Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M. Pabst, Wolfgang P. Fendler, Marija Trajkovic‐Arsic et al.|Journal of Nuclear Medicine|2023Cited by 63
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, Lale Umutlu, David Kersting et al.|Seminars in Nuclear Medicine|2021Cited by 43
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the<sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Jens T. Siveke, Nader Hirmas et al.|Journal of Nuclear Medicine|2023Cited by 34
Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Wolfgang P. Fendler, Kim M. Pabst et al.|Journal of Nuclear Medicine|2024Cited by 26